Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Cyclophosphamide Monohydrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 21 USDMF, 5 CEP/COS, 6 EU WC, 17 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

338 Drugs in Development

338 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

145 FDF Dossiers, 85 FDA Orange Book, 15 Europe, 8 Canada, 9 Australia, 6 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG, SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML), SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML), SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 18 SPI Pharma, 7 DKSH, 4 Faran Shimi Pharmaceutical, 1 Chynops Pharma, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 20 Kerry, 3 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 17 Roquette, 2 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 24 Direct Compression, 17 Thickeners and Stabilizers, 16 Chewable & Orodispersible Aids, 15 Taste Masking, 14 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Disintegrants & Superdisintegrants, 12 Granulation, 10 Coating Systems & Additives, 8 Empty Capsules, 6 Parenteral, 5 Film Formers & Plasticizers, 4 Controlled & Modified Release, 3 Solubilizers, 3 Coloring Agents, 3 Topical, 3 Emulsifying Agents, 1 API Stability Enhancers, 1 Rheology Modifiers

DIGITAL CONTENT

70 News #PharmaBuzz

70 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 Regulatory FDF Prices

11 Regulatory FDF Prices

MARKET PLACE

14 APIs, 18 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 5 USP, 6 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Aarti Pharmalabs	India	AARTI PHARMALABS LTD	35313	CYCLOPHOSPHAMIDE STERILE USP	2021-01-21	Active	II	N/A
28/03/2025	Aarti Pharmalabs	India	AARTI PHARMALABS LTD	37086	CYCLOPHOSPHAMIDE	2022-05-02	Active	II	N/A

Cyclophosphamide Monohydrate

Cyclophosphamide Monohydrate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers

21 USDMF

5 CEP/COS

6 EU WC

17 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

338 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

145 FDF Dossiers

85 FDA Orange Book

15 Europe

8 Canada

9 Australia

6 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG

SOLUTION;INTRAVENOUS - 1GM/5ML (200MG/ML)

SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML)

SOLUTION;INTRAVENOUS - 500MG/2.5ML (200MG/ML)

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Rochem International Inc

18 SPI Pharma

7 DKSH

4 Faran Shimi Pharmaceutical

1 Chynops Pharma

5 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Pramukh Pharmachem

1 Zeal MediPharma

4 ACG Worldwide

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 BASF

4 DFE Pharma

1 Finar

4 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

20 Kerry

3 Lonza Capsugel

11 Microlex e.U

1 NEWEDGE Overseas

2 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qualicaps

17 Roquette

2 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders

24 Direct Compression

17 Thickeners and Stabilizers

16 Chewable & Orodispersible Aids

15 Taste Masking

14 Lubricants & Glidants

INJECTABLE;INJECTION - 100MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 200MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons